4
Changes in Ownership
AGIOS PHARMACEUTICALS, INC. Filed Acc 0001439222-26-000065
Chief Medical Officer sold 2,940 shares at $34.71 ($102,047)
- Chief Medical Officer acquired 8,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
Gheuens Sarah · Chief Medical Officer
Table I: Non-derivative
2 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-04-02 | Exercise or conversion : show line 1 in the form 10b5-1 | +8,500 | 83,217 | D | ||
| 2026-04-02 | Sale : show line 2 in the form 10b5-1 | −2,940 | $34.71 | $102,047 | 80,277 | D |
| Open-market sales · 2,940 sh · avg $34.71 · $102,047 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-04-02 | Exercise or conversion : show line 3 in the form 10b5-1 Performance share units | −8,500 | 8,500 | D |
Loading xslF345X06/wk-form4_1775506198.xml…